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Objective: The primary end point of the Emory Angioplasty versus Surgery 
Trial was a composite of three events: death, Q-wave infarction, and a new 
large defect on 3-year postoperative thallium scan. This study examines the 
clinical significance of Q-wave infarction in the surgical cohort (194 
patients) of the Emory trial. Methods: Twenty patients (10.3%) with Q-wave 
infarctions were identified: 13 patients had inferior Q-wave infarctions and 
seven patients had anterior, lateral, septal, or posterior Q-wave infarctions 
(termed anterior Q-wave infarctions). Results: In theinferior Q-wave infarc- 
tion group, postoperative cardiac atheterization (at 1 year or 3 years) in 11 
patients revealed normal ejection fraction (ejection fraction >55%) in 10 
(91%), no wall motion abnormalities in 10 (91%), and all grafts patent in 10 
(91%). In the anterior Q-wave infarction group, postoperative catheteriza- 
tiOn in six patients revealed normal ejection fractions in five (83%), no wall 
motion abnormalities in three (50%), and all grafts patent in three (50%). 
Average peak postoperative creatine kinase MB levels were as follows: no 
Q-wave infarction (n = 174) 37 -+ 43 IU/L, inferior Q-wave infarction 40 -+ 
27 IU/L, and anterior Q-wave infarction 58 +- 38 IU/L. Mortality in the 20 
patients with Q-wave infarctions was 5% (1/20) at 3 years; in patients 
without a Q-wave infarction it was 6.3% (11/174) (p = 0.64). Of 17 patients 
with a Q-wave infarction who underwent postoperative catheterization, 11
(65%) had a normal ejection fraction, normal wall motion, and all grafts 
patent with an uneventful 3-year postoperative course. Conclusions: The 
core laboratory screening of postoperative electrocardiograms, particularly 
in the case of inferior Q-wave infarctions, appears to identify a number of 
patients as having a Q-wave infarction with minimal clinical significance. 
Q-wave infarction identified in the postoperative p riod seems to be a weak 
end point with little prognostic significance and therefore not valuable for 
future randomized trials. (J Thorac Cardiovasc Surg 1996;112:1447-54) 
T he clinical significance of perioperative myocar- dial infarctions (MIs) after coronary artery by- 
pass graft (CABG) operations is controversial. 
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Some authors report that patients with a perioper- 
ative MI after CABG are significantly more likely to 
have a cardiac event, with an increased in-hospital 
and long-term mortality) 4 Other investigators find 
that a perioperative MI is generally a benign event 
presaging no significant difference in outcome for 
these patients when compared with the prognosis of
patients who have not had a perioperative MI. 5-s 
This variability in outcome is partly a function of the 
different echniques used to identify a perioperative 
MI. Previous studies have defined a perioperative 
MI as the appearance of new or enlarging Q waves, 
elevation in the myocardial fraction of creatine 
kinase (CK-MB), perfusion defects on radionuclide 
scans, or regional wall motion abnormalities on 
echocardiography. 9 
We examined the surgical cohort of patients who 
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had a perioperative Q wave MI (QMI) in the Emory 
Angioplasty Versus Surgery Trial (EAST). 1° EAST 
was a prospective, randomized comparison of 
CABG with percutaneous transluminal coronary 
angioplasty (PTCA) in patients with multivessel 
coronary artery disease. The primary end point was 
a composite of three events: death, QMI, and a large 
ischemic defect identified on thallium scanning at 3 
years. A QMI, related to the index survival proce- 
dure, was defined as the presence of a new Q wave 
that developed uring the course of the trial on a 
predischarge lectrocardiogram. To evaluate the 
value of a QMI as an end point in prospective, 
randomized trials, we reviewed the clinical course of 
those patients with a perioperative QMI, as defined 
in the EAST. 
Patients and methods 
The EAST was a single-institution, prospective, ran- 
domized study comparing PTCA versus myocardial revas- 
cularization in patients with multivessel coronary artery 
disease.S° The primary end point was a composite of three 
events: death, QMI within any time during the 3-year 
follow-up interval, and the presence of a large ischemic 
defect on thallium stress tudies with single-photon-emis- 
sion computed tomography at 3 years. Secondary end 
points included ventricular function, degree of revascular- 
ization at 1 and 3 years, exercise performance, the need 
for subsequent revascularization procedures, the quality 
of life, and costs. Data were analyzed according to the 
intention-to-treat principle. The study was supported by 
the National Heart, Lung, and Blood Institute and ap- 
proved by the Emory University institutional review 
board. Informed consent was obtained by giving a detailed 
presentation of the treatments, without recommending 
one or the other. 
Patients of any age with two- or three-vessel disease 
who had not undergone a previous PTCA or CABG were 
eligible for the study. The EAST encompassed the dates 
of July 13, 1987, through April 15, 1990. Of the 5118 
patients initially screened, 842 patients (16.5%) were 
found to be eligible, and 392 patients (7.7%) agreed to 
participate in the study. The patients were randomly 
assigned to PTCA (198 patients) and CABG (194 pa- 
tients). The baseline demographic and clinical character- 
istics of the randomized patients did not differ significantly 
between the two groups. PTCA was performed by stan- 
dard balloon methods with an attempt to open clinically 
relevant stenoses. CABG was performed with an effort to 
provide complete revascularization. Data were collected 
at baseline and every 6 months for follow-up, with all 
patients being followed up for the duration of the trial. A 
second cardiac catheterization was performed in 87% of 
the eligible patients at 1 year and in 76% at 3 years. 
This present report comprises the 20 patients (10.3%) 
in the surgical cohort of the EAST who were judged to 
have had a perioperative QMI. Electrocardiograms were 
interpreted independently b two experienced electrocar- 
diographers, blinded to the study data, who identified new 
pathologiC Q waves that developed uring the course of 
the trial. In case of disagreement, a third electrocar- 
diographer adjudicated the decision. Q waves were de- 
fined by means of the Minnesota code criteria. HElectro- 
cardiograms taken in the early postoperative p riod, on 
the second or third day, were excluded from review 
whereas predischarge electrocardiograms in patients un- 
dergoing surgical treatment were included. Blood samples 
for measurement of CK and CK-MB were collected every 
8 hours for 24 hours. Peak values for each patient were 
chosen for analysis and the data were presented as the 
mean + standard eviation. 
Statistical analysis was performed with a )(2 test or 
Fisher's exact est for differences in noncontinuous vari- 
ables and the paired t test for continuous variables. 
Statistical significance was defined as p < 0.05. 
Results 
In the EAST, a QMI developed after the initial 
procedure in 20 patients (10.3%) of the CABG 
group and six patients (3.0%) in the PTCA group. 
Among these 20 patients, 11 were male and nine 
female, with an average age of 60.1 _+ 7.9 years. The 
anatomic distribution of the 20 perioperative QMIs 
included inferior QMIs in 13 patients (6.7%), an- 
teroseptal QMIs in three patients (1.5%), lateral 
QMIs in three patients (1.5%), and a posterior QMI 
in one patient (0.5%). The anteroseptal, lateral, and 
posterior QMIs were considered as one group (an- 
terior QMI) for the purposes of analysis. 
The mean peak CK level was 902.0 _+ 639.6 IU/L 
(n = 167) in patients undergoing CABG who did 
not have a perioperative QMI versus 1175.8 _+ 671.5 
IU/L (n = 19) (p = 0.08) in the patients diagnosed 
with a perioperative QMI. The CK level in inferior 
QMI was 1035.4 _+ 523.4 IU/L (n = 13) and in 
anterior QMI, 1480.2 + 896.3 IU/L (n = 6) (p = 
0.187). 
Mean peak CK-MB for patients undergoing 
CABG who did not have a perioperative QMI was 
37.2 - 43.3 IU/L versus 48.3 _+ 32.3 IU/L in patients 
who did have a perioperative QMI (p = 0.2S). Mean 
peak CK-MB levels for patients with an inferior 
QMI was 39.5 _+ 27.2 IU/L and for those with an 
anterior QMI, 57.6 + 38.3 IU/(p = 0.21) (Fig. 1). 
Mean percent CK-MB for patients undergoing 
CABG who did not have a perioperative OMI was 
5.9% -+ 4.0% versus 6.9% _+ 2.9% in those who did 
have a perioperative QMI (p = 0.29); 4.3% _+ 3.5% 
in inferior OMI and 5.4% _+ 3.9% in anterior OMI 
(p = 0.55). 
In the 17 patients having a QMI who underwent 
follow-up cardiac catheterization at I or 3 years, the 
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postoperative jection fraction was a mean of 
70.5% _+ 12.3%, with a significant difference be- 
tween inferior QMI 75.2% _+ 9.1% (n = 11) and 
anterior QMI 62% _+ 13.5% (n = 6) (p < 0.05). 
However, 91% of patients having an inferior QMI 
and 83% of those having an anterior QMI had a 
normal ejection fraction (ejection fraction >55%). 
In the 11 patients with inferior QMIs, 10 patients 
(91%) had all grafts patent with no wall motion 
abnormalities; by contrast, among patients having 
anterior QMIs, three of the six patients (50%) had 
all grafts patent and no wall motion abnormalities. 
Of these 17 patients having perioperative QMIs, 11 
(65%) had a normal ejection fraction, normal re- 
gional wall motion, and all grafts patent with an 
uneventful 3-year postoperative course. Of these 11 
patients, nine (81.8%) had an inferior QMI and two 
(33%) had an anterior QMI. 
The 20 patients with a perioperative QMI had a 
mean intensive care unit stay of 2.1 _+ 0.6 days, with 
a mean hospital stay of 7.1 _+ 1.1 days. Inotropic 
support was evaluated during the postoperative 
period at 12 and 24 hours. Twelve hours after the 
operation two patients were receiving epinephrine 
in dosages of 3.5 and 2.0/xg/kg per minute, respec- 
tively, and one patient was receiving dopamine in a 
dosage of 5 txg/kg per minute. Seventeen patients 
(85%) were not receiving any inotropic support at 
12 hours. At 24 hours all patients were in hemody- 
namically stable condition with no inotropic sup- 
port. 
In the EAST, in-hospital mortality included two 
patients (1%) in the CABG group and two patients 
(1%) in the PTCA group. During the 3 years of the 
study, 12 patients (6.2%) died in the CABG arm and 
14 patients (7.1%) died in the PTCA arm (p = 0.73). 
In the CABG cohort, late death occurred in one of 
20 patients (5%) who were diagnosed with a peri- 
operative QMI, while death occurred in 11 of the 
remaining 174 patients (6.3%) who did not have a 
perioperative QMI (p = 0.64). A cardiac cause 
accounted for eight of the 12 (67%) deaths in the 
CABG group and seven of the 14 (50%) deaths in 
the PTCA group. 
Fig. 2 shows the preoperative and postoperative 
electrocardiograms of five patients who had periop- 
erative inferior Q waves without CK-MB elevation. 
Late cardiac catheterization revealed that ejection 
fraction and regional wall motion were within nor- 
mal limits and all grafts were patent. 
Fig. 3 depicts the preoperative and postoperative 
electrocardiograms of two patients in whom periop- 
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Fig. 1. Mean peak CK-MB levels in patients undergoing 
CABG who did not have perioperative QMI (No QMI) or 
who had inferior (Inf. QMI) (n = 11) or anterior QMI 
(Ant. QMI) (n = 6). Values are mean -+ standard evia- 
tion. 
erative inferior Q waves developed associated with 
an elevation in the peak CK-MB. Late cardiac 
catheterization revealed ejection fraction and re- 
gional wall motion to be within normal imits and all 
grafts to be patent. 
To assess the clinical impact of the combination 
of perioperative Q-wave development and CK-MB 
elevation, we divided the cohort of patients into two 
groups: patients with perioperative Q waves with 
and without elevation of the postoperative CK-MB 
above 50 IU/L. Twelve patients had a CK-MB value 
less than 50 IU/L; nine of these 12 patients had 
follow-up catheterization. Eight of the nine patients 
(89%) had normal ejection fraction, normal wall 
motion, and all grafts patent. Seven patients had 
perioperative CK-MB elevations greater than 50 
IU/L and all seven had postoperative catheteriza- 
tions. Four of the seven (57%) had a normal ejec- 
tion fraction, normal regional wall motion, and all 
grafts patent. 
Discussion 
A perioperative MI is one of the major complica- 
tions after CABG. The reported prevalence of peri- 
operative MI ranges widely from 2% to 23%, yet the 
exact clinical significance of a perioperative MI after 
CABG continues to generate controversy, a2, 13 Sev- 
eral authors report an increase in cardiac events and 
in-hospital and late mortality in patients undergoing 
CABG who have a perioperative MI. Force and 
associates I found that cardiac events (defined as 
death, nonfatal MI, admission to the hospital for 
unstable angina or congestive heart failure) were 
significantly greater in patients with a perioperative 
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Fig. 2. Preoperative and postoperative electrocardiograms of five patients with perioperative inferior 
QMI, with normal associated iagnostic stndies. These patients have only small electrocardiograhic 
changes and are unlikely to have been identified as having had a QMI by our usual clinical surveillance 
system. A, Peak CK-MB, 29 IU/L; ejection fraction, 81%; wall motion by ventriculography, normal. B, Peak 
CK-MB, 34 IU/L; ejection fraction, 82%; wall motion by ventriculography, normal. C, Peak CK-MB, 18 
IU/L; ejection fraction, 72%; wall motion by ventriculography, normal. D, Peak CK-MB, 9 IU/L; ejection 
fraction, 78%; wall movement by ventriculography, normal. E, Peak CK-MB, 30 IU/L; ejection fraction, 
67%; wall motion by ventriculography, normal. 
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Fig. 3. Perioperative and postoperative electrocardiograms of two patients with a perioperative inferior 
QMI and elevated CK-MB levels, but with other diagnostic studies within the normal range. These patients 
have pronounced electrocardiographic c anges and are likely to have been identified as having had a QMI 
by our usual clinical surveillance system. A, Peak CK-MB, 68 IU/L; ejection fraction, 79%; wall movement 
by ventriculography, normal. B, Peak CK-MB, 102 IU/L; ejection fraction, 71%; wall movement by 
ventriculography, normal. 
MI than in patients without a perioperative MI 
(31% vs 12%, p < 0.01). In addition, multiple 
cardiac events were significantly more prevalent in 
this group of patients with a perioperative MI than 
in the group without a perioperative MI (19% vs 
1%, p < 0.001). Another study revealed that the 
probability of remaining free of new cardiac ompli- 
cations at 2 years was 51% in the perioperative MI 
group compared with 96% in patients who did not 
have a perioperative MI. 2 The in-hospital mortality 
in patients with a perioperative MI has been noted 
to be 9.7% versus 1% in those patients without a 
perioperative MI. Hypotension and heart failure 
were significantly more frequent in the periopera- 
tire MI group. 3 Similar results have been obtained 
with intermediate and long-term survival, with 
3-year survivals of 85% in patients with a perioper- 
ative MI compared with 90% in patients without a 
perioperative MI (p < 0.001) and 5-year survivals of 
76% and 90% (p < 01001) in the same groups, 
respectively.3, 4 The risk of death for patients with a 
perioperative MI has been estimated to be 3.1 times 
greater than for comparable patients without a 
perioperative MI. 4 
However, other authors maintain that a perioper- 
ative MI is generally a benign event. Operative or 
in-hospital mortality has been noted to be similar 
between patients with and without a perioperative 
MI. 4-6 In addition, long-term survival was compara- 
ble in patients who had a perioperative MI and in 
those who did not. 6 Gray and colleagues 7 reported 
that there was no significant difference in 5-year 
survival between patients with a perioperative MI 
and those without a perioperative MI (96.8% vs 
94.3%, respectively). 
This variability in survival outcomes in patients 
with a perioperative MI may be a function of several 
factors. The various studies use different diagnostic 
techniques (electrocardiograms, CK-MB elevations, 
radionuclide scans) to identify a perioperative MI, 
making comparisons between studies difficult. False 
positive and false negative results have been noted 
with each of the diagnostic tests. 3' 9. 14 
Several authors have noted the resolution or 
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disappearance of perioperative Q waves. 15' 16 This 
finding may be due to scar contracture or hypertro- 
phy of adjacent myocardium during healing, the 
recovery of stunned myocardium, or the resolution 
of peri-MI edema fluid. 15' 17, 18 In addition, revascu- 
larization of ischemic myocardium ay "unmask" a
preexisting MI in the vectorially opposite myocar- 
dium. For example, the appearance of inferior Q 
waves, which previously had been canceled out by 
ischemic anterior myocardium, become "unmasked" 
with the revascularization f the anterior myocardi- 
urn. 14 Bulkley and Hutchins 19 indicated the low 
sensitivity of electrocardiograms to diagnose aperi- 
operative MI. Of 13 patients with myocardial necro- 
sis on autopsy 1 month after CABG, only three 
patients (23%) had had new Q waves on a postop- 
erative electrocardiogram. 
The CK-MB level is frequently used to detect an 
acute MI. The level of CK-MB rises within the 
serum at 6 to 10 hours, with maximal levels reached 
between 14 and 36 hours. 2° Both ventricular and 
atrial myocardium contain CK-MB isoenzyme, and 
cannulation of the atrium may result in an elevation 
of CK-MB.  21 False elevations of CK-MB levels have 
also been observed with direct-current defibrillation, 
renal failure, hypothyroidism, and mesenteric in- 
farction producing bowel necrosis. 9'22, 23 
A perfusion defect on a radionuclide scan such as 
technetium 99m pyrophosphate is indicative of an 
acute MI. The mechanism of action of 99mTc pyro- 
phosphate is by binding to mitochondrial CA ++ 
within a damaged myocyte. 24As the cell becomes 
irreversibly damaged, intracellular Ca --+ increases 
with a resultant increase in the binding of 99mTc 
pyrophosphate. However, an increased uptake of 
99Tc pyrophosphate has also been observed with a 
remote MI, cardioversion, and a ventricular aneu- 
rysm. 9 Nonetheless, improved diagnostic accuracy 
can be achieved by the correlation of multiple 
diagnostic tests for myocardial necrosis. 2 
The EAST electrocardiography committee iden- 
tified a perioperative QMI in 10.3% (20/194) of the 
patients in the CABG group, compared with a QMI 
rate of 3% (6/198) of the patients in the PTCA 
group (p = 0.004). This perioperative MI rate is 
approximately five times the infarct rate of first-time 
CABG previously reported from Emory University 
during a similar time period. 25 This discrepancy is 
related to the fact that the core laboratory analysis 
of perioperative electrocardiograms is much more 
sensitive in the diagnosis of QMI than our usual 
clinical surveillance system. Fig. 2 illustrates five 
patients identified as having QMIs in EAST with 
only small electrocardiographic changes. All five 
patients had unremarkable perioperative CK-MB 
levels and normal ejection fractions and wall motion 
at late catheterization. These patients are examples 
of patients identified as having a QMI in EAST who 
were not likely to be identified as having a QMI by 
our normal surveillance system. Fig. 3, on the other 
hand, depicts two patients very likely to be identified 
as having a QMI by our usual surveillance system. 
There was no significant difference in the mean 
CK, CK-MB, and percent CK-MB between patients 
in whom perioperative QMI was diagnosed and 
those patients without a perioperative QMI. Al- 
though each of these parameters was greater in the 
patients having an anterior QMI than in those 
having an inferior QMI, the difference did not 
achieve statistical significance. 
The ejection fraction calculated by ventriculogra- 
phy on cardiac atheterization was 69% in both the 
CABG and PTCA groups in EAST. This was not 
different from the ejection fraction of 71% in the 17 
patients with a perioperative QMI. Of note, there 
was a significant difference in the ejection fractions 
between the patients with inferior QMI and anterior 
QMI, 75% versus 62% (p < 0.05), respectively. 
Further analysis of the cardiac atheterization data 
at either 1 or 3 years revealed that 91% (10/11) of 
the patients having inferior QMI and 50% (3/6) of 
those having anterior QMI had all grafts patent and 
no wall motion abnormalities. Although the patients 
having inferior QMI appeared to have a better 
clinical outcome than those having anterior QMI, 
the sample sizes were too small for meaningful 
comparison. 
All patients had been weaned from inotropic 
agents 24 hours after the operation. In-hospital 
mortality occurred in two patients (1%) in the 
CABG group, neither of whom was in the periop- 
erative QMI surgical cohort. During the 3-year 
study interval, death occurred in 5% (1/20) of the 
CABG group with a perioperative QMI, 6.3% (11/ 
174) of the patients in the CABG group without a 
perioperative QMI, and 7.1% (14/198) in the PTCA 
group (p = 0.25). There was no detectable differ- 
ence in clinical outcome in the EAST between 
patients identified as having a QMI after CABG and 
the outcome of the other patients in the trial. 
The best suggestion for diagnosing clinically rel- 
evant myocardial necrosis in the perioperative inter- 
val may be the combination of perioperative Q
waves on the electrocardiogram nd the elevation of 
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perioperative CK-MB levels. When this cohort of 
patients was analyzed by means of this combinat ion 
of criteria, 12 patients had Q waves without CK-MB 
elevation and seven patients had Q waves with 
CK-MB elevation. Eighty-nine percent of the pa- 
tients without CK-MB elevation had normal  find- 
ings on postoperative catheterization, whereas only 
57% of the patients with a combinat ion of CK-MB 
elevation and perioperative Q waves had normal  
findings on catheterization (p = 0.262). Inasmuch as 
a QMI  identified by electrocardiographic criteria 
alone in the postoperative period seems to be a 
weak end point without prognostic importance, per- 
haps the combinat ion of perioperative Q-wave de- 
velopment and CK-MB elevation will more accu- 
rately identify clinically significant perioperative 
myocardial necrosis. 
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Discuss ion 
Dr. Bruce W. Lytle (Cleveland, Ohio). One of the 
advantages of a randomized trial is that the patients are 
studied longitudinally and a lot of other information 
becomes available. What you and your colleagues have 
shown is that an isolated electrocardiographic finding of a 
Q wave in the early postoperative p riod does not neces- 
sarily correlate with enzyme levation, subsequent clinical 
outcome, or wall motion abnormalities. Thus the term 
QMI, at least for this group of patients, is a misnomer. 
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There are Q waves and there are MIs, but Q waves do not 
necessarily identify the MIs. My only question isthis: If we 
are not going to use Q waves to identify perioperative 
MIs, then what are we going to use? You do have a group 
of patients that were documented to have wall motion 
abnormalities at late cardiac catheterization. Can you 
identify anything in the perioperative t sts that predicted 
the occurrence of a late wall motion abnormality, for 
example, enzyme elevation combined with a Q wave, 
perhaps? 
Dr. Hodakowski. That is a very good question, and 
indeed that is a problem in identifying perioperative 
QMIs. These ventriculograms were performed I and 3 
years after the study. The way we at Emory identify a 
perioperative QMI is by having not only electrocardio- 
graphic riteria but also the elevation of CK. Wall motion 
is a very specific way of identifying MIs. Ninety-one 
percent of the patients in the inferior QMI group had 
normal wall motion. So one or two patients of the 20 
patients indeed had abnormal wall motion. That is a good 
point. But not many in this group of patients had abnor- 
mal wall motion. Generally, approximately 50% of pa- 
tients having Q-wave changes and elevated CK-MB levels 
might have abnormal wall motion as well as occluded 
grafts. 
Dr. Lyric. I realize that you were specifically evaluating 
the surgical group, but six patients having PTCA had new Q 
waves. Was there a similar discordance between Q waves 
and other findings for that group, or don't you know? 
Dr. Hodakowski. We do not have that information. I'm 
sorry. 
Dr. Robert B. Wallace (Washington, D.C.). In view of 
these data and the attempt to restrict he ineffective use of 
resources, do you continue in your practice at Emory to 
routinely monitor CK levels and electrocardiograms in the 
postoperative p riod? 
Dr. Hodakowski. Generally we get a postoperative 
electrocardiogram, but the CKs are used on a per-patient 
basis. If we are concerned that the patient may have had 
problems or is hemodynamically unstable or gives other 
indications of having myocardial damage, then we will 
measure CK-MB levels, but it is not a routine. 
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